Omada Health (NASDAQ:OMDA) Now Covered by Analysts at Canaccord Genuity Group

Canaccord Genuity Group initiated coverage on shares of Omada Health (NASDAQ:OMDA - Free Report) in a research note published on Tuesday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $27.00 price target on the stock.

Separately, Wall Street Zen raised shares of Omada Health to a "hold" rating in a research report on Monday, June 16th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $23.57.

Omada Health Price Performance

NASDAQ OMDA traded down $0.05 on Tuesday, hitting $18.25. 1,438,446 shares of the company were exchanged, compared to its average volume of 1,213,277. Omada Health has a 12 month low of $14.14 and a 12 month high of $28.40.

Omada Health Company Profile

Omada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.